Dr. Hsieh on Patient Characterization From RECORD-3 Study in Metastatic RCC
November 8th 2016
James J. Hsieh, MD, medical oncologist, physician-scientist, Memorial Sloan Kettering Cancer Center, discusses overall survival results in the RECORD-3 study based on 3 distinct clear cell metastatic renal cell carcinoma molecular subgroups.